- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 15, 2026 | 8.09M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 8.09M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 8.09M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 8.09M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 8.09M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $132K |
| Capex | Q3 2026 · Mar 31, 2025 | $148K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $1.03M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$115K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $21.3M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $19.48M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $49.66M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $49.1M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $48.37M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $48.15M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $48.06M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $48M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $324.88M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $322.84M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $374.54M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $371.21M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.15 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.07 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.15 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q3 2026 · Mar 31, 2026 | $581K |
| Net Income | Q3 2026 · Mar 31, 2026 | $1.23M |
| Net Income | Q3 2026 · Mar 31, 2025 | $7K |
| Net Income | Q3 2026 · Mar 31, 2025 | $5K |